Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Asthma”

181 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 181 results

Testing effectiveness (Phase 2)Study completedNCT01437735
What this trial is testing

Dose Finding Study for QAW039 in Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 1,043
Testing effectiveness (Phase 2)WithdrawnNCT00967590
What this trial is testing

RO5036505 in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT03387852
What this trial is testing

Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants

Who this might be right for
Asthma
Sanofi 296
Not applicableUnknownNCT02489383
What this trial is testing

Comparison Between Continuous Versus Interval Exercise Training in Asthmatic Patients

Who this might be right for
Asthma
University of Sao Paulo General Hospital 60
Large-scale testing (Phase 3)Study completedNCT00180011
What this trial is testing

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
DiMango, Emily, M.D. 18
Testing effectiveness (Phase 2)Study completedNCT04570657
What this trial is testing

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Who this might be right for
Asthma
AstraZeneca 250
Testing effectiveness (Phase 2)Study completedNCT00317044
What this trial is testing

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

Who this might be right for
AsthmaGERD
AstraZeneca 961
Testing effectiveness (Phase 2)Study completedNCT05186909
What this trial is testing

CM310 in Subjects With Moderate to Severe Asthma

Who this might be right for
Asthma
Keymed Biosciences Co.Ltd 52
Testing effectiveness (Phase 2)Study completedNCT00873860
What this trial is testing

Study to Evaluate the Safety and Efficacy of CAT-354

Who this might be right for
Asthma
MedImmune LLC 357
Testing effectiveness (Phase 2)Looking for participantsNCT06977581
What this trial is testing

Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Who this might be right for
Asthma
Pfizer 252
Not applicableStudy completedNCT00937066
What this trial is testing

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

Who this might be right for
Asthma
AstraZeneca 1,000
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Not applicableLooking for participantsNCT05550402
What this trial is testing

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

Who this might be right for
AsthmaAirway ObstructionAirway Remodeling+1 more
Hat Yai Medical Education Center 60
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Study completedNCT02181335
What this trial is testing

Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

Who this might be right for
Asthma
Boehringer Ingelheim 684
Testing effectiveness (Phase 2)Looking for participantsNCT07301255
What this trial is testing

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

Who this might be right for
Asthma
Enveda Therapeutics 50
Post-approval studies (Phase 4)Study completedNCT04400318
What this trial is testing

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

Who this might be right for
Asthma
Sanofi 109
Post-approval studies (Phase 4)Study completedNCT00139152
What this trial is testing

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

Who this might be right for
Lung Disease
Creighton University 65
Load More Results